Hepatic Sirt6 protects against cholestatic liver disease primarily via inhibiting bile acid synthesis rather than antioxidation or triggering mitochondrial biogenesis
Wen Zhang(Third Affiliated Hospital of Guangzhou Medical University), Liang Sheng(Nanjing Medical University)
Cited by 0
Related Papers
Hypoxia destroys the microstructure of microtubules and causes dysfunction of endothelial cells via the PI3K/Stathmin1 pathway
|Cell & Bioscience|2019|41
NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease
|Theranostics|2020|41
Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
|FEBS Open Bio|2021|14
Hepatic SIRT6 protects against cholestatic liver disease primarily <i>via</i> inhibiting bile acid synthesis
|Journal of Biomedical Research|2024|2